Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 150MG | 0 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE |
002 | TABLET, EXTENDED RELEASE;ORAL | 300MG | 0 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2006-12-14 | |
LABELING; Labeling | SUPPL | 8 | AP | 2007-09-17 | |
LABELING; Labeling | SUPPL | 11 | AP | 2011-01-20 | |
LABELING; Labeling | SUPPL | 17 | AP | 2009-12-15 | |
LABELING; Labeling | SUPPL | 18 | AP | 2011-01-25 | |
REMS; REMS | SUPPL | 20 | AP | 2010-11-19 | |
LABELING; Labeling | SUPPL | 22 | AP | 2011-08-30 | |
LABELING; Labeling | SUPPL | 23 | AP | 2011-10-31 | |
LABELING; Labeling | SUPPL | 30 | AP | 2014-12-13 | STANDARD |
LABELING; Labeling | SUPPL | 33 | AP | 2017-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 36 | AP | 2017-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 39 | AP | 2017-08-25 | STANDARD |
LABELING; Labeling | SUPPL | 42 | AP | 2019-06-12 | STANDARD |
Submissions Property Types
SUPPL | 11 | Null | 7 |
SUPPL | 17 | Null | 7 |
SUPPL | 22 | Null | 15 |
SUPPL | 23 | Null | 15 |
SUPPL | 30 | Null | 31 |
SUPPL | 33 | Null | 7 |
SUPPL | 36 | Null | 15 |
SUPPL | 39 | Null | 7 |
SUPPL | 42 | Null | 7 |
TE Codes
001 | Prescription | AB3 |
002 | Prescription | AB3 |
CDER Filings
ANCHEN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 77284
[companyName] => ANCHEN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"150MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPROPION HYDROCHLORIDE","activeIngredients":"BUPROPION HYDROCHLORIDE","strength":"300MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"12\/14\/2006","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/077284lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"BUPROPION HYDROCHLORIDE","submission":"BUPROPION HYDROCHLORIDE","actionType":"150MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"BUPROPION HYDROCHLORIDE","submission":"BUPROPION HYDROCHLORIDE","actionType":"300MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2006-12-14
)
)